Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hemodynamic Monitoring Enters a New Era

Executive Summary

As critical care migrates from intensive care units to other areas of the hospital, hemodynamic monitors--essential for patient diagnosis and prognosis--must make the move as well. At this year's annual meeting of the Society of Critical Care Medicine, clinicians and researchers discussed the need and the market challenges for hemodynamic monitoring technologies that are simpler to use, less invasive and allow for earlier diagnosis of sepsis and shock.
Advertisement

Related Content

Recent Trends in Hemodynamic Monitoring
Recent Trends in Hemodynamic Monitoring
Market & Industry Briefs
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q1 2008
Market & Industry Briefs
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q1 2008
Start-Up News April 2008
Start-Up News April 2008
Remote Patient Monitoring: The Markets Near and Far

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT035170

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel